Protracted benzodiazepine withdrawal: why the symptoms can outlast the drug.

The medication is long gone, but the anxiety, aches, buzzing and exhaustion remain. Here is what may be keeping them going.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What protracted benzodiazepine withdrawal is

Benzodiazepines are sedative medications prescribed for anxiety, insomnia, muscle spasm and seizures. When they are taken daily for months or years, the brain adapts to them. Stopping, even gradually, lets those adaptations slowly unwind, and for a while the nervous system is more excitable than usual. Most people get through the acute phase within a few weeks.

Protracted withdrawal (sometimes called post-acute withdrawal syndrome, or more recently benzodiazepine-induced neurological dysfunction, BIND) is the name for symptoms that carry on well beyond that window. People describe anxiety and panic, insomnia, muscle tension and pain, pins and needles, inner vibrations, sensitivity to noise and light, nausea and bowel changes, brain fog, depersonalisation and crushing fatigue. Symptoms often wave and window: bad stretches alternating with periods of near-normal.

The neuroplastic contribution

The ATNS Index of Neuroplastic Symptoms takes an unusually detailed position on this entry, quoting Heather Ashton's 1995 description. In the index's framing, protracted withdrawal is clearly not a disease entity. It is better understood as a blend of two things: first, pharmacological effects, as receptor changes the drug caused in the brain slowly reverse; and second, psychological effects of long-term use, including the uncovering of stress-coping difficulties and personal struggles that the medication had kept out of view. These merge into one picture that can be further complicated by the return of the anxiety or depression the drug was first prescribed for. The index concludes that the issues typical of people with neuroplastic symptoms are likely to be common in this group, so an assessment for neuroplastic symptoms should be done.

Neuroplastic symptoms are real physical and emotional symptoms generated by learned patterns in the brain and nervous system, an alarm system stuck on high, rather than by ongoing injury or disease. They are not imaginary and not a character flaw. What makes protracted withdrawal such a fertile ground for them is easy to see:

• The nervous system is genuinely more excitable for a time, so ordinary sensations feel loud and alarming.
• Fear about those sensations (is this permanent? have I damaged my brain?) keeps the threat system switched on, which produces more symptoms.
• Online communities can, with the best intentions, amplify the belief that recovery is unlikely, which is itself a powerful nocebo.

None of this means the pharmacological part is not real. It means the two parts feed each other, and the brain-learned part is the one you can work on directly. Our explainer on central sensitization describes the same mechanism in chronic pain.

What the research shows

Ashton's 1991 paper on protracted withdrawal syndromes from benzodiazepines described, from clinical follow-up, how early withdrawal symptoms merge into longer-lasting ones that can persist for many months, usually improving gradually, though in a few cases persisting even when the drug was restarted. She proposed that tolerance may develop unevenly across brain systems and reverse slowly, while noting that the mechanism remained uncertain.

A 2025 scoping review of 46 studies on long-term neurological consequences of benzodiazepine exposure found that symptoms including tinnitus, digestive problems and fatigue were reported months or years after stopping, but concluded that the prevalence and trajectory of these symptoms could not be determined from the available studies, and that the terminology (withdrawal, protracted withdrawal, PAWS, rebound) is used inconsistently.

Two large internet surveys of people who had stopped benzodiazepines reported that the longest-lasting symptoms were cognitive difficulties, anxiety and agitation, sensory hypersensitivity, body aches, digestive symptoms and fatigue. Those are self-selected samples, so they cannot tell us how common the syndrome is, but they describe the lived experience well, and the symptom list overlaps almost completely with the symptom list for neuroplastic conditions. No published study has yet tested a neuroplastic-symptom approach specifically in this group, so the direct evidence is thin; the case rests on the overlap and on what is known about sensitized nervous systems generally.

Signs the brain may be part of the picture

• Symptoms wax and wane in waves and windows rather than steadily worsening.
• They spike with stress, poor sleep, conflict or reading alarming accounts online, and ease when you are absorbed or relaxed.
• New symptoms appear and old ones fade, or symptoms move around the body.
• You feel intense fear about the sensations and spend a lot of time scanning your body for them.

A solution that addresses it

There is an approach that addresses the brain's contribution directly. Pain and symptom reprocessing combines education about how neuroplastic symptoms arise, somatic tracking (observing sensations with calm curiosity so they stop being read as danger), reducing fear and threat, a graded return to normal activity, emotional awareness and expression work for the stress underneath, and acceptance and commitment skills for living well while the nervous system resettles. It is delivered by trained clinicians and increasingly through digital programmes, and it sits comfortably alongside the slow, medically supervised taper that benzodiazepine discontinuation requires.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. It is not a substitute for your prescriber. If you would like a companion for the daily work, you can join the waitlist.

What to do next

Do not stop or change a benzodiazepine on your own. Abrupt withdrawal can cause seizures. Any taper should be slow and supervised by a prescriber who understands benzodiazepine dependence.

Get other causes checked. Thyroid problems, anaemia, vitamin deficiencies, sleep apnoea and depression can all mimic or worsen withdrawal symptoms. New weakness, fainting, chest pain, seizures or thoughts of harming yourself need urgent care.

Ask whether a neuroplastic pattern fits. If your examination and tests are normal and your symptoms match the list above, ask your clinician whether a sensitized nervous system is contributing and whether a reprocessing or ACT-based approach could help alongside medical care. Our pages on ACT for persistent symptoms and making a flare plan are good places to start, and the condition index lists other stress-sensitive diagnoses.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.